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To generate the Saudi KACST induced Pluripotent StemCell lineNo 1
(SKiPSc1) cell line, four reprogramming Yamanaka factors (Oct3/4,
Sox2, c-Myc, and Klf4) (Takahashi et al., 2007; Yu et al., 2007) were de-
livered toHNFFs by Sendai viral infection (Life Technologies, Invitrogen)
(Ban et al., 2011). SKiPSc1 colonies exhibited a characteristic round
shape morphology with small, tightly packed cells with a high nucle-
us/cytoplasm ratio and prominent nucleoli (Fig. 1A). The Sendai virus
is non-integrating and the absence of exogenous reprogramming fac-
tors and the SeV vector in the cells was conﬁrmed by PCR analysis
(Fig. 1B). Pluripotency was veriﬁed by endogenous gene expression of
pluripotent stem cell markers Oct4, Sox2, Nanog, Klf4 and c-MYc by
PCR (Fig. 1B). The colonies were also positive for alkaline phosphatase
activity (Fig. 1C). Furthermore, pluripotent surface marker expression
of Tra-1-60, Oct4 and SOX2 was conﬁrmed by immunostaining
(Fig. 1D). Finally, iPSCs single cells were able to generate embryoid bod-
ies when cultured under certain conditions (Fig. 1E).
1. Materials and methods
1.1. Neonatal foreskin samples collection and processing
Neonatal foreskin samples were obtained after routine circumcision
of newborn males. Informed consent was obtained from the child's fa-
ther. The foreskin tissue was removed according to Good Clinical Prac-
tice (GCP) and conventional aseptic techniques. Collected samples
were transferred to 15 ml plastic test tubes (Thermo Fisher Scientiﬁc,
Inc) with 5 ml Dulbecco's Modiﬁed Eagle's Medium (DMEM,
LifeTechnologies) supplemented with 10% fetal bovine serum (FBS,
LifeTechnologies) and penicillin (100 U/ml)-streptomycin (100 μg/the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A) Phase contrast image of HNF cells and SKiPSc1. B) PCR analysis of gene expression of pluripotencymarkers, and Sendai virus vector (SeV). C)Alkalin staining of HNF and SKiPSc1.
D) Detection of pluripotency markers in SKiPSc1 by Immunoﬂuorescence. E) Embryoid bodies (EBs) at day 7, and emerging cells from attached EBsat day 14.
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placed in separate wells of a six-well plate (duplicated) and allowed to
adhere to the plastic surface for approximately 5 min at room tempera-
ture. DMEM, supplemented with 10% FBS, 100 U/ml of penicillin, and
100 μg/ml of streptomycin in 1 ml aliquots was added to each well.
The explant ﬁbroblast cultures were maintained at 37 °C in 5% CO2
and 95% room air. The explant cultures were evaluated under phase
contrast microscopy.
Human dermal ﬁbroblasts (passages 3–5) from neonatal foreskin
explants were grown in T-75 ﬂasks (Thermo Fisher Scientiﬁc, Inc) and
subcultured in 6- or 24-well plates (Thermo Fisher Scientiﬁc, Inc)
using DMEM supplemented with 10% FBS, penicillin (100 U/ml), and
streptomycin (100 μg/ml). Fibroblast cultures were grown and incubat-
ed at 37 °C in 5% CO2 and 95% room air.
1.2. iPS cell reprogramming
The HNFFs were expanded and reprogrammed. Brieﬂy, HNFFs were
expanded in DMEM medium (LifeTechnologies) containing 10% FBS
(Life Technologies) andGlutaMAX (Life Technologies). Cells were trans-
duced with Sendai viral vectors expressing human Oct3/4, Sox2, Klf4,
and c-Myc. (Life Technologies) (MOI according to manufacturer's in-
structions). Transduced cells were plated on one well of 6-well plate.
SKiPSc1was cultured inDMEM/F12withGlutaMAX(Life Technologies),
10% FBS (Life Technologies. The medium was replenished every two
days for one week. At day 7, cells were detached using 0.05% Trypsin-
EDTA (LifeTechnologies) and plated on 100 mm non-treated dish coat-
ed with Vitronectn containing DMEM/F12. The following day, medium
was changed to E8 medium (Life Technologies), the medium was
replenished every two days. The Cells were maintained in these condi-
tions until uniform colonies were generated and iPS cell colonies were
mechanically isolated for expansion in feeder free conditions on
Vitronectin in the presence of E8 medium. iPSC lines were routinely
split using 0.5 mMEDTA and thawed in the presence of kinase inhibitor
(Y-27,632, Sigma) during 24 h after thawing.
1.3. Alkaline phosphatase (AP) staining
AP staining was performed on one well of 6-well plate using the al-
kaline phosphatase staining Kit (STEMGENT, USA) according to the
manufacturer's directions. Colonieswere identiﬁed based on the follow-
ing morphological criteria: well deﬁned-border, three-dimensionality,
and tightly packed cells.
1.4. PCR
RNA was isolated from the SKiPSc1 cells using the RNeasy micro kit
(Qiagen) according to the manufacturer's instructions. Reverse tran-
scriptionwas performed on total RNA (500 ng) using randomhexamers
with Superscript III Reverse Transcriptase (Life Technologies). The cDNA
was used as a template for PCR ampliﬁcation of the viral backbone and
reprogramming genes (SeV, Klf4, Oct3/4, Sox2, Nanog and c-Myc).
Primer sequences were provided by the company (Life Technologies).Primer sequences (5` to 3`) were as follows: OCT4_F: CCTCACTTCACT
GCACTTGTA; OCT4_R: CAGGTTTTCTTTCCCTAGCT; SOX2_F: ATGTCCCA
GCACTACCAGAG; SOX2_R: GCACCCCTCCCATTTCCC; NANOG_F: TTTG
TGGGCCTGAAGAAAACT; NANOG_R: AGGGCTGTCCTGAATAAGCAG;
KLF4_F: GGTCGGACCACCTCGCCTTACAC; KLF4_R: CTCAGTTGGGAACT
TGACCA; c-Myc_F: CTGAAGAGGACTTGTTGCGGAAAC; c-Myc_R: TCTC
AAGACTCAGCCAAGGTTGTG; B-Actin_F: AAACTGGAACGGTGAAGGTG;
B-Actin _R: AGAGAAGTGGGGTGGCTTTT PCR products were separated
on a 2.0% agarose gel and visualized with ethidium bromide.
1.5. Immunostaining
For immunostaining of iPSC, cellswere ﬁxed for 20min at room tem-
perature in 4% paraformaldehyde solution in PBS; they were then
washed several times in PBS, and blocked for 30 min in PBS with 5%
fetal bovine serum. Cells were then stained with primary antibodies
overnight at 4 °C, rinsed with PBS, and incubated with secondary anti-
bodies for 1 h at RT. Primary antibodies used for characterization of
iPSC and iPSC-derived cells were TRA-1-60 (SANTA CRUZ
BIOTECHNOLOGY, INC, # sc-21705), OCT4 (SANTA CRUZ
BIOTECHNOLOGY, INC, #sc-5279,) and SOX2 (SANTA CRUZ
BIOTECHNOLOGY, INC, #sc-17,320). Texas Red-conjugated goat-anti-
mouse IgG (SANTA CRUZ BIOTECHNOLOGY, INC, #sc-2781,), FITC-
conjugated donkey-anti-goat IgG (SANTA CRUZ BIOTECHNOLOGY,
INC, #sc-2024), and FITC-conjugated goat-anti-mouse IgM (SANTA
CRUZ BIOTECHNOLOGY INC, # sc-2082) were used as secondary anti-
bodies. DAPI was used for counterstaining. Stained cells were analyzed
by using IN Cell Analyzer 2000 Imaging System (GE Healthcare Life
Sciences).
1.6. Embryoid body (EB) formation
iPSC colonies were passaged as small aggregates using 0.05%
Trypsin-EDTA and suspended in lEB medium: Knockout™ DMEM/F12
(Life Technologies) with GlutaMAX (Life Technologies), 10% KnockOut
Serum Replacement (Life Technologies), 0.1 mM 2-mercaptoethanol
(sigma), 1 × Non-Essential Amino Acids (Life Technologies) The cell ag-
gregateswere cultured in suspension in untreated Petri dishes to gener-
ate embryoid bodies. After 7 days, embryoid bodies (EBs)±were plated
onto gelatin-coated 6-well plates and incubated for another 14 days for
spontaneous differentiation.
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